MoonLake Immunotherapeutics

MLTX · Nasdaq

MoonLake Immunotherapeutics (MLTX) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for MoonLake Immunotherapeutics in 2026. The next earnings report is expected on November 17, 2026.

Earnings calendar

Next earnings date

17 Nov 2026

In 87 days

EPS estimate

-0.81

Revenue estimate

Past earnings

Date	EPS actual	Revenue actual	1d	5d	30d
10 Aug 2026	-0.84 (+8.5%) estimate -0.92	0 estimate 0	+2.37%	-2.41%	+4.37%
10 May 2026	-0.98 (-9.9%) estimate -0.89	0 estimate 0	+2.37%	-2.41%	+4.37%
22 Feb 2026	-0.93 (+3.4%) estimate -0.96	0 estimate 0	+2.37%	-2.41%	+4.37%

10 Aug 2026

EPS actual

-0.84 (+8.5%)

estimate -0.92

Revenue actual

estimate 0

Price reaction

+2.37%

-2.41%

30d

+4.37%

10 May 2026

EPS actual

-0.98 (-9.9%)

estimate -0.89

Revenue actual

estimate 0

Price reaction

+2.37%

-2.41%

30d

+4.37%

22 Feb 2026

EPS actual

-0.93 (+3.4%)

estimate -0.96

Revenue actual

estimate 0

Price reaction

+2.37%

-2.41%

30d

+4.37%

Beat Miss usd

Latest earnings analysis

MoonLake Immunotherapeutics beat consensus estimates in its latest earnings report, with EPS of -$0.84 versus an estimate of -$0.9178 and revenue of $0 meeting expectations. In the prior quarter, EPS missed expectations while revenue also met estimates.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or radiographic axial spondyloarthritis. MoonLake Immunotherapeutics was founded in 2021 and is headquartered in Zug, Switzerland.

Sector: Healthcare
Industry: Biotechnology
Country: Switzerland
Exchange: Nasdaq
CEO: Jorge Santos da Silva
Employees: 100
IPO date: 20 Oct 2020
ISIN: KY61559X1045
Website: moonlaketx.com

Frequently asked questions

When does MoonLake Immunotherapeutics (MLTX) next report earnings?

MoonLake Immunotherapeutics (MLTX) is scheduled to report earnings on November 17, 2026.

What was MoonLake Immunotherapeutics's most recent earnings date?

MoonLake Immunotherapeutics (MLTX) last reported earnings on August 10, 2026.

Where is MoonLake Immunotherapeutics stock listed?

MoonLake Immunotherapeutics (MLTX) is listed on Nasdaq.